Pediculosis capitis remains a persistent public health issue, especially in developing countries where resistance to standard neurotoxic pediculicides like permethrin is increasingly prevalent. This study aimed to compare the effectiveness of alternative treatment options against the standard care in a resource-limited setting. We conducted a single-blind randomized controlled trial involving three primary schools in Chachoengsao Province, Thailand (ClinicalTrials.gov: NCT06332872). Eighty-five female participants ages 6-13 years with active infestations were enrolled. Schools were randomly assigned to three treatment arms: 1) oral ivermectin (200 µg/kg) on Days 0 and 7; 2) 1% permethrin shampoo on Days 0 and 7, or 3) 4% dimethicone liquid gel as a single dose on Day 0. The primary outcome was the cure rate, defined as the absence of live lice and viable nits upon clinical assessment on Day 9. Of the 66 participants included in the final per-protocol analysis, oral ivermectin achieved a cure rate of 95.5% (21/22), which was significantly higher than that of the 1% permethrin standard of care (37.0%; 10/27) and the 4% dimethicone physical suffocant (29.4%; 5/17) (P <0.001). Although dimethicone achieved high initial parasitic clearance on Day 0 (88.2%), a rapid reinfestation rate of 58.8% was observed by Day 9, indicating that a single-dose protocol may be clinically insufficient. Adverse events were mild and temporary across all groups. Oral ivermectin appears significantly more effective than both 1% permethrin and single-dose 4% dimethicone in this population. These findings suggest that permethrin resistance is clinically prevalent and relevant in this area.

Personal care products are often dynamically formulated in situ. Variations in the chemistry of the base components (e.g., their polydispersities or ionic contents) require extensive off-line rheological analysis to ensure the products meet benchmarks for performance and thus consumer satisfaction. An in-line alternative for rheological quality control and monitoring thus has the potential to improve efficiency on industrial pipelines. Therefore, we demonstrate optical coherence tomography velocimetry (OCT-V) for the in-line processing of a shampoo based on SLES and CAPB with varying concentrations of salt. OCT-V is a noninvasive quasi-elastic light scattering technique, capable of spatially resolved velocity measurements with an axial depth resolution of 9 μm and a penetration depth of 1.5 mm into the samples. Our in-line apparatus uses infrared light (the wavelength is 1315 nm) and has been optimized for live manufacturing with a 200 L test rig at the Unilever R&D lab. The addition of salt to the shampoo is used for in situ formulation to increase the viscosity, inducing the spherical-to-wormlike micelle transition. To create in-line rheological benchmarks, we measured time averaged velocity profiles and transient velocity fluctuations in the shampoo formulations at imposed flow rates of Q = 500 and 1000 L/h. For a shampoo formulation with 1.1% NaCl salt, fits of the Hagen-Poiseuille equation to velocity profile data give flow rates that are in close agreement with the imposed values, Q HP = 502 ± 2 L/h and 944 ± 4 L/h, corresponding to a 0.4% and 5.6% error, respectively. Combined with measurement of the longitudinal pressure drop, this could be used to calculate constitutive properties, such as the viscosity. The standard deviation of the distribution of transient velocity fluctuations is a decreasing function of salt concentration due to the increasing viscosity. If calibrated to the desired end product, the velocity fluctuations could also be used as a reproducible indicator of product quality on industrial pipelines.

Skin infections are common complications in both humans and animals. Because of the increased incidence of multi-drug resistant (MDR) skin infections, essential oils have been suggested as potential alternatives to the classic antimicrobials. The goal of this study was to evaluate the minimum inhibitory and bactericidal/fungicidal concentrations (MIC and MBC/MFC) of commercially available products containing essential oils, zinc gluconate, or 4% chlorhexidine. Microbroth dilution technique was performed on clinical isolates of MDR Staphylococcus pseudintermedius (MDR-SP; n = 10), Pseudomonas aeruginosa (PA; n = 10), and Malassezia pachydermatis (MP; n = 10). For MDR-SP, essential oil-containing products showed median MICs of 1:240 and 1:320. The chlorhexidine shampoo had a MIC of 1:128,000 (0.312 µg/mL), whereas zinc gluconate products had median MICs of 1:320 and 1:160. Three essential oil-containing shampoos (MBC 1:40), the zinc gluconate (MBC 1:40), and the chlorhexidine (MBC 1:64,000 [0.625 µg/mL]) reached an MBC. For PA, essential oil-containing products showed median MICs of 1:30 and 1:80. The zinc-gluconate products had a median MIC of 1:160, whereas the chlorhexidine shampoo had a median MIC of 1:4,000 (10 µg/mL). Only the zinc-gluconate products (MBC 1:80) and the chlorhexidine shampoo (MBC 1:2,000 [20 µg/mL]) reached an MBC. For MP, essential oil-containing and zinc-gluconate products showed lower median MICs (1:4,800 and 7,200) for shampoos compared with other formulations (1:160 and 1:320), whereas the chlorhexidine shampoo had a median MIC of 1:80,000 (0.5 µg/mL). These results suggest that natural topical compounds can be an effective alternative to treat skin infections in companion animals. Further in vivo studies are needed to clinically confirm this study's results.

There are studies in the literature on zinc pyrithione and selenium disulfide containing shampoos for the treatment of seborrheic dermatitis, but we have not been able to find a study that clearly evaluates the duration of relapses.

Novel personal care products are necessary to cope with the growing market demand for sustainable green products. In this context, this work deals with the formulation and fundamental physicochemical and rheological characterization of different natural personal care products using bioactive fractions from Chondrus crispus red macroalgae extracted under optimized green conditions. Body milks, body oils and shampoos were supplemented with soluble extracts with antioxidant features recovered after hydrothermal (200 °C) and microwave (170 °C)- and ultrasound (80 °C)-assisted extraction of the red macroalgae used as raw material. Formulated products were also compared with those prepared using (±)-α-tocopherol and butylhydroxytoluene standards. Body scrubs were formulated with the remaining solids (<2.25%) after microwave hydrodiffusion and gravidity treatment of the macroalgae. Results indicated that selected extracts provided personal care products with similar or even better physicochemical, color and viscous features than those supplemented with (±)-α-tocopherol or butylhydroxytoluene commercial antioxidants. Rheological profiles indicated that it is possible to develop personal care products with adequate viscous behavior (102−105 mPa s, at 1 s−1), comparable with their synthetic counterparts. To conclude, the addition of antioxidant extracts led to lower apparent viscosity values suggesting an advantage from the skin applicability point of view, jointly with the absence of both the hysteresis phenomenon and water syneresis of the proposed formulations.

No information is available on the clinical use of salicylic acid on the skin during breastfeeding. Because it is unlikely to be appreciably absorbed or appear in breastmilk, it is considered safe to use during breastfeeding.[1] Avoid application to areas of the body that might come in direct contact with the infant's skin or where the drug might be ingested by the infant via licking.

Exfoliative dermatitis (ED) or erythroderma is defined as diffuse erythema and scaling of the skin involving more than 90% of the total body skin surface, which can be caused by variety of systemic and cutaneous diseases, such as infection, including dermatophytosis. Dermatophytosis is a superficial fungal infection of keratinized tissue caused by dermatophytes. There are only few case reports of ED due to dermatophytosis in literature. A 39-year-old male present with history of diffuse erythematous macules and scales almost on entire body due to dermatophytosis was reported. The diagnosis of dermatophytosis was confirmed by direct microscopic examination, fungal culture, and histopathological examination. Patient was treated with 2% ketoconazole shampoo and two pulses of 1-week of 200 mg itraconazole twice a day for each month. Clinical improvement was showed on the 7th day of observation characterized by decreasing of erythematous macules and scales. Mycological and clinical improvements were obtained on the 29th day of observation. The etiology of ED should be determined in order to give an appropiate treatment.

In this study, the in-situ conversion of the synthesized Co-Al layered double hydroxide (Co-Al LDH) nanosheets to three dimensional hierarchical zeolitic imidazolate framework-67 (3D HZIF-67) was presented as a cost-effective, highly efficient, flexible and robust sorbent to carry out the microextraction process. In the first stage, the anodized aluminum foil was prepared electrochemically. Then, the Co-Al LDH precursor was constructed on the surface of the previously-prepared anodized Al foil applying in-situ formation approach. The procedure is followed by the conversion of the prepared Co-Al LDH film to 3D HZIF-67 film via a facile solvothermal method without adding cobalt salt. The in-situ prepared 3D HZIF-67-anodized Al was used for the thin film microextraction (TFME) of caffeine. The effective factors in TFME procedure were investigated and optimized through applying Central Composite Design (CCD). In the obtained optimal condition, the calibration curves for TFME-HPLC-UV of caffeine were linear in the range of 1-200 µg L-1 with the coefficient of determination (r2) higher than 0.9915. The limits of detection were 0.33 and 0.38 µg L-1, in water and urine matrices, respectively. Moreover, the enrichment factors (EFs) and absolute recoveries (%AR) were also calculated as 173-198 and 57.1%-65.3%, respectively. The inter-day relative standard deviations (RSDs) were evaluated as the method precision for 20 and 200 µg L-1 of spiked sample and were between 4.9-6.1%. The repeatability of the preparation step was investigated as batch-to-batch reproducibility and it was found to be 4.9%; as a result, the reproducibility of the presented film was approved. Finally, the proposed method was utilized to determine caffeine (as the model analyte) from different types of real samples including urine, coffee, beverage (Pepsi) and shampoo. The obtained recoveries (higher than 88%) confirmed the capability of the method for real sample analysis.

Androgenetic alopecia (AGA) and acne vulgaris are two conditions commonly seen by dermatologists. Androgens and the androgen receptors play an essential role in the manifestation of both conditions, and some systemic therapies function by interfering in this pathway. The use of topical antiandrogen therapies has gained traction in recent years due to their potential efficacy in treating AGA and acne vulgaris, as well as their reduced adverse effects compared with systemic drugs. This review discusses the role of androgens in skin physiology and pathology and assesses the potential efficacy and safety of three topical antiandrogen therapies in the treatment of AGA and acne vulgaris. A literature review utilizing the PubMed, US Clinical Trials, and SCOPUS databases was conducted to search for randomized clinical trials, systematic reviews, cohort studies, case reports, and other relevant published studies on the pathogenesis and treatment of each condition with topical finasteride, ketoconazole shampoo, and cortexolone 17α-propionate (C17P). The results demonstrated that topical formulations of finasteride, ketoconazole, and C17P are promising treatments for male pattern hair loss, especially topical finasteride in combination with topical minoxidil. Limited studies have shown C17P to have potential in treating acne vulgaris in both males and females. Minimal adverse effects have been reported in clinical trials for all topical therapies, although topical finasteride is still contraindicated in pregnancy. Recognizing the preliminary evidence, more peer-reviewed studies on topical antiandrogen treatments for AGA and acne vulgaris are necessary before definitive recommendations can be made regarding efficacy and safety. There is also a critical need to include more women in study populations for these treatments.